AgeX Therapeutics Receives Extension Of Time To Attain Compliance With Stock Exchange Continued Listing Requirements
AgeX Therapeutics Inc 00X40:
AGEX THERAPEUTICS RECEIVES EXTENSION OF TIME TO ATTAIN COMPLIANCE WITH STOCK EXCHANGE CONTINUED LISTING REQUIREMENTS